Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Dougherty

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Veterinary Research|June 1, 1975
Physiologic studies of experimentally grain-engorged cattle and sheepR W Dougherty, J L Riley, A L Baetz, et al.
The Biochemical Journal|September 1, 1984
Secretagogue-induced phosphoinositide metabolism in human leucocytesR W Dougherty, P P Godfrey, P C Hoyle, et al.
Drug and Chemical Toxicology|January 1, 1985
Reproductive toxicity and lack of dominant lethal effects of 2,4-dinitrotoluene in the male ratR W Lane, G S Simon, R W Dougherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Differential stimulation of the respiratory burst and lysosomal enzyme secretion in human polymorphonuclear leukocytes by synthetic diacylglycerolsC C Cox, R W Dougherty, B R Ganong, et al.
Pancreas|August 1, 1996
Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylationE M Hadac, D V Ghanekar, E L Holicky, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphatesW Pendergast, B R Yerxa, J G Douglass, et al.
Protein Expression and Purification|March 1, 1997
Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram bindingW J Rocque, W D Holmes, I R Patel, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Veterinary Research|June 1, 1975
Physiologic studies of experimentally grain-engorged cattle and sheepR W Dougherty, J L Riley, A L Baetz, et al.
The Biochemical Journal|September 1, 1984
Secretagogue-induced phosphoinositide metabolism in human leucocytesR W Dougherty, P P Godfrey, P C Hoyle, et al.
Drug and Chemical Toxicology|January 1, 1985
Reproductive toxicity and lack of dominant lethal effects of 2,4-dinitrotoluene in the male ratR W Lane, G S Simon, R W Dougherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Differential stimulation of the respiratory burst and lysosomal enzyme secretion in human polymorphonuclear leukocytes by synthetic diacylglycerolsC C Cox, R W Dougherty, B R Ganong, et al.
Pancreas|August 1, 1996
Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylationE M Hadac, D V Ghanekar, E L Holicky, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphatesW Pendergast, B R Yerxa, J G Douglass, et al.
Protein Expression and Purification|March 1, 1997
Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram bindingW J Rocque, W D Holmes, I R Patel, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Pageof 3